Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy
Immune checkpoint blockade (ICB) therapy targeting PD-L1 via monoclonal antibody (mAb) has shown extensive clinical benefits in the diverse types of advanced malignancies. However, most patients are completely refractory to ICB therapy owing to the PD-L1 recycling mechanism. Herein, we propose photo...
Hoofdauteurs: | , , , , , , , , , |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Elsevier
2024-03-01
|
Reeks: | Acta Pharmaceutica Sinica B |
Onderwerpen: | |
Online toegang: | http://www.sciencedirect.com/science/article/pii/S221138352300360X |